IceBath: NOICE vs Nothing (NOICE-Icebath)

May 14, 2026 updated by: Thomas Caruso, Stanford University

NOICE: A Prospective, Randomized, Crossover Study (NOICE vs. Nothing)

This prospective, randomized, 2-period crossover study seeks to evaluate the effect of the non-visual immersive technology-based audio biofeedback intervention, delivered through devices such as NOICE device or Quest 3, on cold pain threshold within participants.

Study Overview

Detailed Description

This study addresses the research gap in understanding how non-visual immersive technology-based audio biofeedback intervention impacts pain perception in clinical settings. It is important to explore this because non-visual immersive technology-based audio biofeedback intervention may serve as a non-pharmaceutical, non-visual immersive technology-based audio biofeedback alternative to traditional visual-based distraction methods like virtual reality.

The investigators hypothesize that participants using the non-visual immersive technology-based audio biofeedback device will report an increased pain threshold compared to not using the device. This knowledge could improve information on the perception of pain for participant who prefer not to use Virtual Reality (VR) headsets.

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Palo Alto, California, United States, 94304
        • Lucile Packard Childrens Hospital Stanford

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Ages 18 years and older
  • English-speaking
  • Intact hearing
  • No self-reported or clinically diagnosed acute or chronic medical conditions that may affect safe participation

Exclusion Criteria:

  • Use chronotropic heart medications
  • Use pain medications
  • Current hearing loss
  • Currently taking beta blockers, or opioids or other prescription pain medications
  • History of chronic pain or acute pain syndromes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group 1
Participants first perform the task with non-visual immersive technology-based audio biofeedback using the dominant hand, followed by without non-visual immersive technology-based audio biofeedback using the non-dominant hand.
Participants receive real-time auditory feedback during cold pain endurance tasks.
Participants complete the same cold pain endurance tasks without any non-visual immersive technology-based auditory feedback.
Experimental: Group 2
Participants first perform the task with non-visual immersive technology-based audio biofeedback using the non-dominant hand, followed by without non-visual immersive technology-based audio biofeedback using the dominant hand.
Participants receive real-time auditory feedback during cold pain endurance tasks.
Participants complete the same cold pain endurance tasks without any non-visual immersive technology-based auditory feedback.
Experimental: Group 3
Participants first perform the task without non-visual immersive technology-based audio biofeedback using the dominant hand, followed by with non-visual immersive technology-based audio biofeedback using the non-dominant hand.
Participants receive real-time auditory feedback during cold pain endurance tasks.
Participants complete the same cold pain endurance tasks without any non-visual immersive technology-based auditory feedback.
Experimental: Group 4
Participants first perform the task without non-visual immersive technology-based audio biofeedback using the non-dominant hand, followed by with non-visual immersive technology-based audio biofeedback using the dominant hand.
Participants receive real-time auditory feedback during cold pain endurance tasks.
Participants complete the same cold pain endurance tasks without any non-visual immersive technology-based auditory feedback.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain score
Time Frame: Immediately after intervention
Pain sensitivity will be measured by Numerical Rating Pain Scale. Participants will rank pain scores on a sliding scale from 0 = No Pain to 10 = Worst possible pain
Immediately after intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ISO Ergonomic scale
Time Frame: immediately after intervention
The scale has 6 items. Scores ranges from 1-5 (1 = strongly disagree and 5 = strongly agree)
immediately after intervention
System Usability Scale (SUS) Score
Time Frame: immediately after intervention
The scale has 10 items. Scores ranges from 1-5 (1 = strongly disagree and 5 = strongly agree)
immediately after intervention
Device satisfaction
Time Frame: immediately after intervention
To evaluate the overall impact of device satisfaction of the spatial audio stimulation device, participants will complete the Patient Technology Satisfaction Survey. Participants will rank each factor on a Likert scale from 1 = not at all to 5 = completely.
immediately after intervention
Anxiety Level
Time Frame: Immediately after intervention
Participants will complete the Visual Analog Scale for Measuring Anxiety (VAS-A) immediately following each group of levels tests, where they will rank anxiety scores on a sliding scale from 0 = No anxiety/fear to 100 = Worst possible anxiety/fear
Immediately after intervention
Cold pain endurance
Time Frame: Periprocedural
To evaluate Cold Pain Endurance, total time (in seconds) that the participant's hand remains immersed in ice water will be recorded. Start time is defined as the moment immediately prior to immersion, and stop time as the moment the hand is withdrawn.
Periprocedural

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 10, 2026

Primary Completion (Actual)

April 2, 2026

Study Completion (Actual)

April 2, 2026

Study Registration Dates

First Submitted

November 5, 2025

First Submitted That Met QC Criteria

November 6, 2025

First Posted (Actual)

November 12, 2025

Study Record Updates

Last Update Posted (Actual)

May 18, 2026

Last Update Submitted That Met QC Criteria

May 14, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Non-visual immersive technology-based audio biofeedback intervention

Subscribe